S1PR1 and B-cell chronic lymphocytic leukemia: However, signaling via B-cell receptor and CD40 in CLL cells has been shown to inhibit S1PR1 preventing cells from getting into circulation where they would be ultimately more vulnerable to cytotoxic drugs [276].